Nevakar spins off ophthalmic-only company Vyluma

Video

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Karl Stonecipher ASCRS 2025
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Paul Karpecki, OD, FAAO
Related Content
Child undergoing eye exam Image credit: AdobeStock/AlexisS/peopleimages.com

CooperVision’s Generation Sight initiative expands its reach for myopia management treatment

Jordana Joy, Associate Editor
June 25th 2025
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
European Commission approves low-dose atropine eye drop Ryjunea, Santen announces - Image credit: ©artjazz—stock.adobe.com

European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

Hattie Hayes
June 5th 2025
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Podcast
iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia ©OHishi_Foto—stock.adobe.com

iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia

Emily Kaiser Maharjan, Assistant Managing Editor
June 4th 2025
Article
Trends in atropine prescribing and dosing before, during, and after the COVID-19 pandemic - Image credit: ©Viacheslav Yakobchuk—stock.adobe.com

Trends in atropine prescribing and dosing before, during, and after the COVID-19 pandemic

Lynda Charters
June 2nd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.